课题基金 / 基金详情

Remote Ischaemic Preconditioning for Heart Surgery (RIPHeart-Study)

Remote Ischaemic Preconditioning for Heart Surgery (RIPHeart-Study)
心脏手术的远程缺血预处理(RIPHeart 研究)
批准号:
129494800
负责人:
Professor Dr. Patrick Meybohm
金额:
$0.0万
依托单位国家:
德国
项目类别:
Clinical Trials
财政年份:
2010
资助国家:
德国
项目状态:
已结题
起止时间:
2009-12-31 至 2013-12-31

项目摘要

项目成果

Professor Dr. Patrick Meybohm的其他基金

相似基金

相关文献

中文摘要
翻译
心脏手术与可预见的心肌、神经和肾功能障碍的发生率有关,这是围手术期发病率和死亡率的重要原因。在许多临床情况下,非生命组织的短暂性缺血可增强远处器官的耐受性,以应对随后的长期缺血事件,这种现象被称为远程缺血预适应。我们假设,与没有积极干预相比,远程缺血预适应可以改善手术后患者的预后。我们进行了一项前瞻性、随机、双盲、多中心对照试验,包括2070名接受体外循环心脏手术的患者。患者将被随机分为远程缺血预适应组和对照组,前者接受4个周期的短暂性上肢缺血/再灌注治疗,后者在麻醉诱导后将血压袖带充气至高于动脉收缩压15 mm Hg,后者接受4个周期的短暂性上肢‘伪’充气/通气至20 mm Hg的压力。主要终点是术后30天内的综合结果(全因死亡、非致命性心肌梗死、任何新的中风和/或急性肾功能衰竭)。次要终点是手术后1年内、住院时间、心肌损伤、心肌功能(超声心动图)、新出现的试验纤颤、神经认知功能测试和急性肾损伤的复合终点的任何组成部分。
英文摘要
Cardiac surgery is associated with a predictable incidence of myocardial, neurological and renal dysfunction that account for significant perioperative morbidity and mortality. Transient ischaemia of nonvital tissue has been shown to enhance the tolerance of remote organs to cope with a subsequent prolonged ischaemic event in a number of clinical situations, a phenomenon known as remote ischaemic preconditioning. We hypothesise that remote ischaemic preconditioning improves patient’s outcome after surgery compared to no active intervention. We conduct a prospective, randomised, double-blind, multicentre, controlled trial including 2070 patients undergoing cardiac surgery in which cardiopulmonary bypass is used. Patients will be randomized either to the remote ischaemic preconditioning group receiving four cycles of transient upper limb ischaemia/reperfusion using a blood-pressure cuff inflated to a pressure 15 mm Hg higher than the systolic arterial pressure after induction of anaesthesia, or to the control group receiving four cycles of transient upper limb ‘pseudo’-inflation/deflation to a pressure of 20 mm Hg. Primary endpoint is a composite outcome (all-cause mortality, non-fatal myocardial infarction, any new stroke, and/or acute renal failure) within 30 days after surgery. Secondary endpoints are any component of the composite endpoint within 1 year after surgery, length of hospital stay, myocardial damage, myocardial function (echocardiography), new onset of a trial fibrillation, neurocognitive function test, and acute kidney injury.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/s00395-012-0314-0
发表时间: 2013-01-01
期刊: BASIC RESEARCH IN CARDIOLOGY
影响因子: 9.5
作者: [Albrecht, Martin, Zitta, Karina, Meybohm, Patrick]
通讯作者: Meybohm, Patrick
Activities of cardiac tissue matrix metalloproteinases 2 and 9 are reduced by remote ischemic preconditioning in cardiosurgical patients with cardiopulmonary bypass
体外循环心脏外科患者的远程缺血预处理降低了心脏组织基质金属蛋白酶 2 和 9 的活性
DOI: 10.1186/1479-5876-12-94
发表时间: 2014
期刊: Journal of Translational Medicine
影响因子: 7.4
作者: [Zitta K, Meybohm P, Bein B, Grünewald M, Lauer F, Steinfath M, Cremer J, Zacharowski K, Albrecht M]
通讯作者: Albrecht M
Liberal transfusion strategy to prevent mortality and anaemia-associated, ischaemic events in elderly non-cardiac surgical patients (LIBERAL-Trial)
海外基金